In this study, a derivative of the natural marine compound ageladine A, compound 25, was found to act as a potential STAT3 inhibitor through STAT3-dependent reporters and cell-based screening strategies, which inhibited STAT3 transcriptional activity and cancer cell growth in the micromolar range. This evidence concerns the gene STAT3 and cancer.